ARW vs RGTI

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 3/9, indicating significant concerns in profitability, leverage, and operating efficiency. Despite this, the company shows resilience through solid revenue growth (13% YoY), consistent earnings beats (25.62% average surprise over last 4 quarters), and a reasonable Debt/Equity ratio of 0.48. Valuation appears attractive relative to peers with a P/E of 13.08 versus sector average of 89.76 and a Price/Book under 1, though low margins and declining recent EPS growth (-0.8% QoQ) temper optimism. The stock trades below its Graham Number ($157.92) and intrinsic value estimate ($212.3), suggesting potential undervaluation, but weak profitability metrics and lack of Altman Z-Score data limit confidence in financial stability.

RGTI presents a paradoxical profile with a stable Piotroski F-Score of 6/9 and exceptional liquidity (Current Ratio 37.42), yet it is fundamentally decoupled from its valuation. The company exhibits an extreme Price-to-Sales ratio of 928.32 and negative revenue growth (-17.90%), suggesting the current price is driven by speculation rather than financial performance. Despite analyst 'Buy' ratings, the combination of severe operating losses (-1209.69% margin) and aggressive insider selling indicates significant downside risk.